Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma

scientific article

Amplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3748/WJG.V12.I27.4338
P932PMC publication ID4087744
P698PubMed publication ID16865775
P5875ResearchGate publication ID298738372

P50authorBanchob SripaQ30004087
P2093author name stringMasanao Miwa
Narong Khuntikeo
Temduang Limpaiboon
Patcharee Jearanaikoon
Vajarabhongsa Bhudhisawasdi
Jongkonnee Thanasai
P2860cites workGenetic aberrations detected by comparative genomic hybridization in biliary tract cancersQ77961970
Genomic amplification of orthodenticle homologue 2 in medulloblastomasQ24294737
BH-3-only BIK functions at the endoplasmic reticulum to stimulate cytochrome c release from mitochondriaQ28205892
Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinomaQ30396926
The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expressionQ33707642
Intrahepatic cholangiocarcinoma in ThailandQ33845493
Cancer control in ThailandQ33958636
Expression of ST13 in colorectal cancer and adjacent normal tissuesQ34382223
Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstreamQ34683632
Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assayQ35842067
The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progressionQ35951880
Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.Q36080231
ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditionsQ38455863
Increased expression of thymidine phosphorylase in tumor tissue in proportion to TP-expression in primary normal tissueQ39078551
Increased nitrosamine and nitrate biosynthesis mediated by nitric oxide synthase induced in hamsters infected with liver fluke (Opisthorchis viverrini).Q41660744
Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liverQ43086184
The role of thymidine phosphorylase and thrombospondin-1 in angiogenesis and progression of intrahepatic cholangiocarcinomaQ43943699
Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.Q43998981
Liver fluke infection and cholangiocarcinoma: model of endogenous nitric oxide and extragastric nitrosation in human carcinogenesisQ44031371
Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer.Q44134120
Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosisQ44360204
Role of thymidine phosphorylase on invasiveness and metastasis in lung adenocarcinomaQ44549287
Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-riboseQ44783905
Comparative study between DNA copy number aberrations determined by quantitative microsatellite analysis and clinical outcome in patients with stomach cancerQ44886566
Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assayQ49051437
Comprehensive allelotyping of human intrahepatic cholangiocarcinoma.Q53322004
Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma.Q53362194
A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers.Q53409005
Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables.Q53635649
Microsatellite alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.Q53649713
Allelic losses of loci at 3p25.1, 8p22, 13q12, 17p13.3, and 22q13 correlate with postoperative recurrence in breast cancerQ73773615
Overexpression of MDM2 protein in intrahepatic cholangiocarcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathological featuresQ74237378
Microsatellite alterations in liver fluke related cholangiocarcinoma are associated with poor prognosisQ74603356
P433issue27
P407language of work or nameEnglishQ1860
P921main subjectcholangiocarcinomaQ124292
Liver flukeQ1326939
liver fluke-related cholangiocarcinomaQ19000504
P304page(s)4338-4344
P577publication date2006-07-01
P1433published inWorld Journal of GastroenterologyQ15708885
P1476titleAmplification of D22S283 as a favorable prognostic indicator in liver fluke related cholangiocarcinoma
P478volume12

Reverse relations

cites work (P2860)
Q34978321Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.
Q39328328Copy number profiling of tumor suppressor genes in head and neck cancer
Q39720644Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma
Q34508893Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand
Q38188515Genomic and transcriptional alterations of cholangiocarcinoma

Search more.